• Apr 14, 2025

MPS chief puts revamp of world's oldest bank to market test with Mediobanca bid

When a group of Harvard Business School students visited Italy's Monte dei Paschi di Siena in January, they gathered notes to build a case study on how to turn around a bank. The strength of that case may now depend on whether shareholders on Thursday approve CEO Luigi Lovaglio's surprise 12-billion-euro ($13.6 billion) hostile takeover offer for rival Mediobanca, made just days after the student visit. Advisory group Institutional Shareholder Services has urged shareholders to reject the plan as it leaves "little margin for error", while rival Glass Lewis is in favour, saying Lovaglio's track record provides guarantees for shareholders.

  • Apr 14, 2025

Stock market’s extreme moves portend lasting trouble for traders

(Bloomberg) -- A knee-jerk reaction to President Donald Trump’s 90-day pause on broad tariffs propelled US stocks to one of their best days on record last week. Ironically, that could be a harbinger of tough times for equity investors.Most Read from BloombergThe Secret Formula for Faster TrainsNYC Tourist Helicopter Crashes in Hudson River, Killing SixEven Oslo Has an Air Quality ProblemInside the Quiet, Extravagant Expansion of the Frick CollectionLisbon Mayor Wants Companies to Help Fix City’s

  • Apr 14, 2025

3 Reasons to Sell CNMD and 1 Stock to Buy Instead

Over the last six months, CONMED shares have sunk to $51.84, producing a disappointing 19.7% loss - worse than the S&P 500’s 7.3% drop. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

  • Apr 14, 2025

3 Reasons CHWY is Risky and 1 Stock to Buy Instead

Even during a down period for the markets, Chewy has gone against the grain, climbing to $34.90. Its shares have yielded a 22.7% return over the last six months, beating the S&P 500 by 29.9%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

  • Apr 14, 2025

3 Reasons MGPI is Risky and 1 Stock to Buy Instead

MGP Ingredients has gotten torched over the last six months - since October 2024, its stock price has dropped 63.7% to $28.87 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

  • Apr 14, 2025

3 Reasons to Avoid AMWD and 1 Stock to Buy Instead

Shareholders of American Woodmark would probably like to forget the past six months even happened. The stock dropped 38% and now trades at $58.36. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

  • Apr 14, 2025

3 Reasons to Sell XRX and 1 Stock to Buy Instead

Xerox has gotten torched over the last six months - since October 2024, its stock price has dropped 60.1% to $4.06 per share. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

  • Apr 14, 2025

3 Reasons to Sell TSLA and 1 Stock to Buy Instead

Tesla currently trades at $255.91 and has been a dream stock for shareholders. It’s returned 441% since April 2020, blowing past the S&P 500’s 90.9% gain. The company has also beaten the index over the past six months as its stock price is up 16.8%.

  • Apr 14, 2025

3 Reasons RHI is Risky and 1 Stock to Buy Instead

Shareholders of Robert Half would probably like to forget the past six months even happened. The stock dropped 28.1% and now trades at $48.67. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.